Lexicon Pharmaceuticals, Inc. (LXRX)
1.52
-0.13
(-7.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.55
+0.03
(+1.97%)
After-Hours: 20:00
Lexicon Pharmaceuticals Free Cash Flow : -64.99M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -64.99M |
| March 31, 2026 | -38.80M |
| December 31, 2025 | -67.85M |
| September 30, 2025 | -73.89M |
| June 30, 2025 | -103.98M |
| March 31, 2025 | -169.77M |
| December 31, 2024 | -181.12M |
| September 30, 2024 | -208.39M |
| June 30, 2024 | -196.17M |
| March 31, 2024 | -185.64M |
| December 31, 2023 | -162.37M |
| September 30, 2023 | -134.63M |
| June 30, 2023 | -112.38M |
| March 31, 2023 | -98.54M |
| December 31, 2022 | -90.18M |
| September 30, 2022 | -90.21M |
| June 30, 2022 | -88.13M |
| March 31, 2022 | -86.54M |
| December 31, 2021 | -88.24M |
| September 30, 2021 | -99.68M |
| June 30, 2021 | -122.73M |
| March 31, 2021 | -146.20M |
| December 31, 2020 | -143.06M |
| September 30, 2020 | -133.13M |
| June 30, 2020 | 97.98M |
| Date | Value |
|---|---|
| March 31, 2020 | 117.37M |
| December 31, 2019 | 113.74M |
| September 30, 2019 | 110.94M |
| June 30, 2019 | -101.94M |
| March 31, 2019 | -127.58M |
| December 31, 2018 | -148.70M |
| September 30, 2018 | -155.25M |
| June 30, 2018 | -167.09M |
| March 31, 2018 | -146.85M |
| December 31, 2017 | -185.62M |
| September 30, 2017 | -200.85M |
| June 30, 2017 | -202.06M |
| March 31, 2017 | -217.65M |
| December 31, 2016 | -175.86M |
| September 30, 2016 | 138.76M |
| June 30, 2016 | 148.32M |
| March 31, 2016 | 163.57M |
| December 31, 2015 | 183.87M |
| September 30, 2015 | -86.30M |
| June 30, 2015 | -81.83M |
| March 31, 2015 | -68.86M |
| December 31, 2014 | -75.70M |
| September 30, 2014 | -93.17M |
| June 30, 2014 | -96.17M |
| March 31, 2014 | -98.04M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol Myers Squibb Co. | 11.44B |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 22.61B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.192M |
| Cash from Investing (Quarterly) | -16.46M |
| Cash from Financing (Quarterly) | -0.512M |
| Free Cash Flow Per Share (Quarterly) | -0.021 |
| Free Cash Flow to Equity (Quarterly) | -10.73M |
| Free Cash Flow to Firm (Quarterly) | -6.583M |
| Free Cash Flow Yield | -10.93% |